Search results

Records found: 1  
Your query: Author Sysno/Doc.kind = "^sllk_un_auth 0039102 xcla^"

  1. 1.Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial

    Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial  / du Bois A., Minarik T. ... [et al.] .  Onkológia. - ISSN 1336-8176 . - Roč. 11, č. 1 (2016), s. 57-58  
    C 3069
    article

    article



  This site uses cookies to make them easier to browse. Learn more about how we use cookies.

Accept allSettingsReject all